Pacific Biosciences of California (PACB) Institutional Ownership
13F filers reported holding 42.6% of Pacific Biosciences of California (PACB) shares as of Sep 30, 2026, across 178 filers.
- Held by 13F filers
- 42.6%
- Sep 30, 2026
- 13F filers
- 178
- quarter ended Sep 30, 2026
- 13F value
- $315.7M
- 133.3M shares
- Quarter's fund flow
- Mild distribution
- 13 new · 31 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Gibson James R II | See Remarks | Acquired · Option exercise | 500,000 | $1.18 | ↗ |
| Oct 6, 2026 | Gibson James R II | See Remarks | Disposed · Open-market sale | 661,815 | $3.11 | ↗ |
| Oct 6, 2026 | Gibson James R II | See Remarks | Disposed · Option exercise | 500,000Stock Option (right to buy) | — | ↗ |
| Aug 17, 2026 | Van Oene Mark | See Remarks | Disposed · Open-market sale | 26,911 | $1.13 | ↗ |
| Aug 10, 2026 | Van Oene Mark | See Remarks | Acquired · Grant / award | 489,130 | — | ↗ |
| Aug 10, 2026 | Van Oene Mark | See Remarks | Acquired · Grant / award | 1,967,888Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | MOHR MARSHALL | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | Gibson Christopher | director | Acquired · Grant / award | 74,497Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | Smith Christopher M | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | Valantine Hannah | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | LIVINGSTON RANDALL S | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | Ericson William W. | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | MILLIGAN JOHN F | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Jun 3, 2026 | ORDONEZ KATHY | director | Acquired · Grant / award | 223,492Stock Option (right to buy) | — | ↗ |
| Apr 8, 2026 | Gibson Christopher | director | Acquired · Grant / award | 57,473 | — | ↗ |
| Apr 8, 2026 | Gibson Christopher | director | Acquired · Grant / award | 77,842Stock Option (right to buy) | — | ↗ |
| Apr 1, 2026 | Gibson James R II | See Remarks | Disposed · Open-market sale | 88,185 | $1.37 | ↗ |
| Mar 3, 2026 | Gibson Christopher | director | Acquired · Grant / award | 53,913 | — | ↗ |
| Mar 3, 2026 | Gibson Christopher | director | Acquired · Grant / award | 73,087Stock Option (right to buy) | — | ↗ |
| Mar 3, 2026 | HENRY CHRISTIAN O | See Remarks | Disposed · Open-market sale | 12,497 | $1.51 | ↗ |
* Holdings as reported for Sep 30, 2026, 48 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Pacific Biosciences of California do institutions hold?
13F filers reported holding 42.6% of Pacific Biosciences of California's shares as of Sep 30, 2026, across 178 filers.
How many 13F filers hold Pacific Biosciences of California?
Pacific Biosciences of California was held by 178 13F filers as of Sep 30, 2026.
Not investment advice.

